Overview
This webinar helps in understanding ciclesonide as a molecule. it’s unique properties and it’s therapeutic use in OAD management is discussed.
Faculty
Dr. Sundeep Salvi
MD, DTCD, DNB, PhD(UK), FCCP (USA), FICS, Hon FRCP (London), Chairman and Director Chest Research and Training Private Limited, Pune, Distinguished Professor of Research Symbiosis International University, Pune President, Indian Chest Society, 2023-2024, Member, Board of Directors, GOLD, Member, Scientific Committee, GINA, Chair, Chronic Respiratory Diseases Section, Global Burden of Disease, India, Member, Steering Committee on Air Pollution and Health, Ministry of Health and Family Welfare, Government of India.
Chairman and Director Chest Research and Training Private Limited, Pune Member, Board of Directors, GOLD Member, Governing Council - Indian Chest Society, International Advisory Board Member, Lancet Respiratory Medicine Chair, Chronic Respiratory Diseases Section, GBD, India
Dr. Lancelot Pinto
M.B.B.S.. DNB - Resp, MSc –EpidemiologyFellow -COPD Sleep Medicine | McGill University Canada FCCP -USA | Consultant – Respirologist P D Hinduja HospitalMumbai
Dr. Sujeet Rajan
MBBS, MD (Chest), DETRD, DNB (Respiratory Medicine), FCCP (USA)Consultant Chest Physician, Bombay Hospital Institute of Medical Sciences, Honorary Consultant Chest Physician, Bhatia Hospital, Mumbai, India
Dr Murali Mohan
MBBS, MD (General Medicine), MRCP (Edinburgh), FRCP (Glasgow)Special Certificate in Respiratory Medicine, British Thoracic SocietySenior Consultant Pulmonologist Narayana Hrudayalaya, Bangalore Academic Director, Department of Internal Medicine, Narayana Hrudayalaya, Bangalore, IndiaResources
External Resources
Refining the Choice of ICS in OAD Management
Also Read
Our Research
